Hessler Megan J, Cyrs Austin, Krenzke Steven C, Mahmoud El Shaimaa, Sikasunge Chummy, Mwansa James, Lodh Nilanjan
Department of Clinical Laboratory Science, Marquette University, Milwaukee, Wisconsin, United States of America.
Department of Biology, Marquette University, Milwaukee, Wisconsin, United States of America.
PLoS One. 2017 Dec 11;12(12):e0189400. doi: 10.1371/journal.pone.0189400. eCollection 2017.
Schistosomiasis is one of the major Neglected Tropical Diseases (NTDs) in sub-Saharan Africa. In sub-Saharan Africa, two major human schistosome species namely Schistosoma mansoni and S. haematobium often occur sympatrically largely affecting children. Recognizing the public health impact of Schistosomiasis, the World Health Organization (WHO) is urging member states to regularly treat at least 75% and up to 100%, of all school-aged children at risk of morbidity. For control strategies based on targeted mass drug administration (MDA) to succeed it is essential to have a simple and sensitive test for monitoring the success of these interventions. Current available diagnostic tests, such as egg detection in stool by Kato-Katz (KK) for S. mansoni and detection of eggs or blood (hematuria) in urine for S. haematobium have reduced sensitivity in low intensity settings. The objective of the study was to evaluate active single or duo schistosome infections in school children following MDA using molecular diagnostics (PCR) on filtered urine samples and comparing that against traditional diagnostic tests. This cross-sectional study was conducted among 111 school children aged 7-15 years in Chongwe and Siavonga Districts in Zambia. Species-specific cell-free repeat DNA fragment were amplified from 111 filtered urine samples. Our approach detected eight times more positive cases (total 77) than by KK (9) for S. mansoni and six times more (total 72) than by hematuria (11) for S. haematobium and even more against urine filtration (77 compared to only 6). The same pattern was observed when stratified for age group and sex specific analysis with 100% sensitivity and specificity devoid of any cross amplification. In addition, 69 individuals (62%) were co-infected by both parasites. We have demonstrated a significantly higher prevalence of both species than indicated by the traditional tests and the persistent maintenance of reservoir of infection after MDA. Our approach is an effective means of detecting low intensity infection, which will enhance the effectiveness of surveillance and assess the impact of MDA control programs against schistosomiasis.
血吸虫病是撒哈拉以南非洲地区主要的被忽视热带病之一。在撒哈拉以南非洲,两种主要的人体血吸虫物种,即曼氏血吸虫和埃及血吸虫,常常同域出现,对儿童影响很大。认识到血吸虫病对公共卫生的影响,世界卫生组织(WHO)敦促成员国定期治疗至少75%乃至高达100%的所有有发病风险的学龄儿童。为使基于目标群体大规模药物治疗(MDA)的控制策略取得成功,拥有一种简单且灵敏的检测方法来监测这些干预措施的成效至关重要。当前可用的诊断检测方法,如用Kato-Katz(KK)法检测粪便中的曼氏血吸虫虫卵,以及检测尿液中的埃及血吸虫虫卵或血尿,在低感染强度情况下敏感性降低。本研究的目的是利用分子诊断方法(PCR)对过滤后的尿液样本进行检测,评估学龄儿童在接受MDA后活动性单种或两种血吸虫感染情况,并与传统诊断检测方法进行比较。这项横断面研究在赞比亚的琼圭和西亚翁加地区的111名7至15岁学龄儿童中开展。从111份过滤后的尿液样本中扩增出物种特异性的无细胞重复DNA片段。我们的方法检测出的曼氏血吸虫阳性病例(共77例)比KK法(9例)多8倍,检测出的埃及血吸虫阳性病例(共72例)比血尿检测法(11例)多6倍,甚至比尿液过滤法(77例对比仅6例)更多。在按年龄组和性别进行分层分析时也观察到相同模式,敏感性和特异性均为100%,且无任何交叉扩增。此外,69人(62%)同时感染了两种寄生虫。我们已证明这两种血吸虫的流行率显著高于传统检测方法所显示的,并且在MDA后感染源持续存在。我们的方法是检测低强度感染的有效手段,这将提高监测的有效性,并评估MDA控制项目对血吸虫病的影响。